Table 7.
Clinical application of antiretroviral assays
Analyte | Time after dose (hours) | Curve Utilized | Concentration (ng/mL) |
---|---|---|---|
Abacavira | 1.8 | High | 4866 |
Bictegravirb | 10.8 | High | 4825 |
Cabotegravir | 984 | High | 2421 |
Dolutegravira | 1.8 | High | 3072 |
Doravirine | 11.6 | High | 1072 |
Emtricitabineb | 10.8 | High | 1268 |
Lamivudinea | 1.8 | High | 2236 |
Tenofovirb | 10.8 | Low | 11.5 |
Superscript letters (a and b) represent samples from patients receiving combination antiretroviral therapy.